A Nomogram for Predicting Overall Survival in Patients with Uterine Leiomyosarcoma: a SEER Population-based Study
Overview
Authors
Affiliations
To establish and validate a nomogram for the estimation of overall survival of patients with uterine leiomyosarcoma (uLMS). Information on patients diagnosed as uLMS was retrospectively retrieved from the Surveillance, Epidemiology, and End Results database. The patients were randomly assigned into the training and the validation cohorts. Univariate and multivariate analyses were used to determine the independent prognostic factors for building a nomogram for predicting overall survival. The predictive accuracy was evaluated based on the concordance indices and the calibration plots. A nomogram that combined age, marital status, tumor size, Surveillance, Epidemiology, and End Result stage, surgery and radiation was established. The internal and external concordance indices were 0.748 and 0.745, respectively. The calibration plots approached 45 degrees. The nomogram might be an effective tool for predicting the survival of patients with uLMS.
Liu Z, Gao F, Min T, Shang Q, Wang B, Pu J Front Oncol. 2024; 14:1417226.
PMID: 39386189 PMC: 11461169. DOI: 10.3389/fonc.2024.1417226.
A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years.
Huang J, Chen Y, Li Z, Chen M, Huang D, Zhu P Front Oncol. 2024; 14:1343533.
PMID: 38410101 PMC: 10894944. DOI: 10.3389/fonc.2024.1343533.
Zhuang A, Yue X, Tong H, Zhang Y, He F, Lu W Front Endocrinol (Lausanne). 2023; 14:1160817.
PMID: 37534215 PMC: 10393052. DOI: 10.3389/fendo.2023.1160817.
Wei J, Liu L, Li Z, Ren Z, Zhang C, Cao H J Int Med Res. 2023; 51(7):3000605231188647.
PMID: 37523501 PMC: 10392527. DOI: 10.1177/03000605231188647.
Feng Z, Li Y J Cancer Res Clin Oncol. 2023; 149(13):11735-11748.
PMID: 37405479 DOI: 10.1007/s00432-023-05052-y.